Navigation Links
Cardiologists and Cardiac Surgeons Perform First Trans-catheter Aortic Valve Replacement at Loma Linda University Medical Center
Date:11/21/2013

LOMA LINDA, CA. (PRWEB) November 21, 2013

A joint team of cardiologists, cardiac and vascular surgeons and cardiac anesthesiologists completed the first trans-catheter aortic valve replacement (TAVR) at Loma Linda University Medical Center (LLUMC) on Oct. 28, and the patient is doing well. LLUMC is the first hospital in the Inland Empire to perform this type of procedure.

This new therapy is used to treat certain patients who are symptomatic with severe aortic valve stenosis, shortness of breath, chest pain, heart failure, light-headedness, and syncope. TAVR provides an alternative to open heart surgery for patients who are considered inoperable.

The team consisted of cardiologists Anthony Hilliard, MD, and Kenneth Jutzy, MD; cardiothoracic surgeons Anees Razzouk, MD, and Rosario Floridia, MD; vascular surgeon Ahmed Abou-Zamzam, MD; Jason Gatling, MD, and Ryan Lauer, MD from anesthesia and echocardiographers Ramesh Bansal, MD, and Ramdas Pai, MD.

"This procedure requires the collaboration of cardiologists and cardiac surgeons to evaluate and select patients in order to provide the best outcomes," said Dr. Razzouk, chief of cardiothoracic surgery at LLUMC. "Loma Linda University Medical Center was selected as the site to do this procedure, partially because our traditional approach to patient care has been a team approach, especially when it comes to cardiac patients. We work daily with cardiologists and other professionals to present the best options of care for our patients."

Typically, aortic valve replacement (AVR) can be lifesaving for patients with symptomatic aortic stenosis, however the process would normally involve opening the chest, stopping the heart and placing the patient on a cardiopulmonary bypass machine.

Because of the invasive nature of this approach, about 30% of patients with severe aortic stenosis who also have concomitant comorbidities are not considered surgical AVR candidates and would likely not survive beyond two years after symptom onset.

“With TAVR, patients can receive the treatment they need and experience a better quality of life,” said Dr. Jutzy, head of the department of cardiology.

TAVR is a nonsurgical approach that yields survival benefits equivalent to conventional AVR surgery but with shorter procedure times and reduced anesthesia requirements. The procedure involves replacing a narrowed aortic valve using less invasive catheter-based techniques, and the new valve is attached to a catheter inserted into the aorta. Procedure time for TAVR is generally two to three hours.

The TAVR program at Loma Linda University International Heart Institute includes a comprehensive team approach to assessment and treatment involving all participating departments. The team includes an intake coordinator, interventional cardiologists, cardiothoracic surgeons, cardiac anesthesiologists, echocardiographers, radiology professionals, vascular surgeons, nurses and technologists specially trained in TAVR protocols.

For more information on the TAVR procedure, please call 1-855-LLU-VALVE (855-558-8258) or e-mail TAVR(at)llu(dot)edu.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11356644.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Local Medical Marketing for Cardiologists Now Comes with Performance Guarantees
2. Pets a Boon for the Human Heart, Cardiologists Say
3. Mobile Health Apps & Solutions Market (Cardiac Monitoring, Diabetes Management Devices) Worth $20.7 Billion by 2018 - New Report by MarketsandMarkets
4. New study reports on the high cost of cardiac surgery healthcare associated infections
5. Study questions hypothermia treatment for cardiac arrest
6. Effect of lowering of body temperature for adults with cardiac arrest prior to hospital arrival
7. New Study Reports on the High Cost of Cardiac Surgery Healthcare Associated Infections
8. Northern California Medical Associates (NCMA) Welcomes Jaime Molden, M.D. Cardiac Electrophysiologist to the NCMA Cardiovascular Services Team
9. Hospitalized children more likely to die after cardiac arrest during night shift
10. Allegheny General Hospital Streamlines Testing for Liver Transplant Patients with Advanced Cardiac MRI
11. Researchers at Pace University Explore the Lived Experiences of Families Members That Have the Possible Risk of Genetic Mutations That Cause Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook ... Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the ... is their favorite way to cook a hot dog, far outpacing other cooking methods ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac ... significant negative impact on long-term patient survival, reports a team of UPMC researchers ... this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, ... public. , Dr. Maisel, founder of Retina Group of New York , ...
(Date:5/26/2016)... Indianapolis, Indiana (PRWEB) , ... May 26, 2016 ... ... national provider of healthcare supply chain solutions, today announced the organization has earned ... management meets international standards and is compliant with all rules and policies associated ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
Breaking Medicine Technology: